Gotham Asset Management »

Theravance Biopharma shares owned by Gotham Asset Management

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Gotham Asset Management from 13F filings

Historical chart of Gotham Asset Management investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Gotham Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Gotham Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $424k 23k 18.71
2016-12-31 $305k 9.6k 31.87
2015-12-31 $733k 70k 10.53

More positions owned by Gotham Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tidal Trust I Gotham Enhncd (GSPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Snowflake Com Shs (SNOW)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Value Etf (VTV)
Microsoft Corporation (MSFT)
Spdr Series Trust State Street Spd (BIL)
Broadcom (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Airbnb Com Cl A (ABNB)

View all positions for Gotham Asset Management

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
D. E. Shaw & Co
Acadian Asset Management
State Street Corporation
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Dimensional Fund Advisors
Oasis Management
UBS Group
Two Sigma Investments

View all funds holding Theravance Biopharma